EXICURE, INC. (XCUR) reporting calendar
EXICURE, INC. files periodic reports with the SEC as XCUR on Nasdaq. Atlas tracks 37 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 27 Jul 2026 – 15 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 29 May 2026
- Reports on record
- 37
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 52 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open XCUR market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 29 May 2026 | 59 days | 0001698530-26-000057 |
| 10-K | 31 Dec 2025 | 25 Mar 2026 | 84 days | 0001698530-26-000028 |
| 10-Q | 30 Sep 2025 | 7 Nov 2025 | 38 days | 0001698530-25-000100 |
| 10-Q | 30 Jun 2025 | 8 Aug 2025 | 39 days | 0001698530-25-000077 |
| 10-Q | 31 Mar 2025 | 27 Jun 2025 | 88 days | 0001698530-25-000056 |
| 10-K | 31 Dec 2024 | 18 Mar 2025 | 77 days | 0001698530-25-000019 |
| 10-Q | 30 Sep 2024 | 14 Nov 2024 | 45 days | 0001698530-24-000117 |
| 10-Q | 30 Jun 2024 | 13 Aug 2024 | 44 days | 0001698530-24-000089 |
| 10-Q | 31 Mar 2024 | 17 Jun 2024 | 78 days | 0001698530-24-000068 |
| 10-K | 31 Dec 2023 | 6 Jun 2024 | 158 days | 0001698530-24-000051 |
| 10-Q | 30 Sep 2023 | 16 May 2024 | 229 days | 0001698530-24-000030 |
| 10-Q | 30 Jun 2023 | 11 Aug 2023 | 42 days | 0001698530-23-000091 |
| 10-Q | 31 Mar 2023 | 14 Jul 2023 | 105 days | 0001698530-23-000079 |
| 10-K | 31 Dec 2022 | 27 Mar 2023 | 86 days | 0001698530-23-000029 |
| 10-Q | 30 Sep 2022 | 14 Nov 2022 | 45 days | 0001698530-22-000088 |
| 10-Q | 30 Jun 2022 | 15 Aug 2022 | 46 days | 0001698530-22-000058 |
| 10-Q | 31 Mar 2022 | 16 May 2022 | 46 days | 0001698530-22-000033 |
| 10-K | 31 Dec 2021 | 25 Mar 2022 | 84 days | 0001698530-22-000019 |
| 10-Q | 30 Sep 2021 | 19 Nov 2021 | 50 days | 0001698530-21-000105 |
| 10-Q | 30 Jun 2021 | 12 Aug 2021 | 43 days | 0001698530-21-000091 |
| 10-Q | 31 Mar 2021 | 12 May 2021 | 42 days | 0001698530-21-000056 |
| 10-K | 31 Dec 2020 | 11 Mar 2021 | 70 days | 0001698530-21-000031 |
| 10-Q | 30 Sep 2020 | 12 Nov 2020 | 43 days | 0001698530-20-000076 |
| 10-Q | 30 Jun 2020 | 12 Aug 2020 | 43 days | 0001698530-20-000059 |
| 10-Q | 31 Mar 2020 | 14 May 2020 | 44 days | 0001698530-20-000034 |
| 10-K | 31 Dec 2019 | 10 Mar 2020 | 70 days | 0001698530-20-000013 |
| 10-Q | 30 Sep 2019 | 7 Nov 2019 | 38 days | 0001698530-19-000146 |
| 10-Q | 30 Jun 2019 | 8 Aug 2019 | 39 days | 0001698530-19-000125 |
| 10-Q | 31 Mar 2019 | 8 May 2019 | 38 days | 0001698530-19-000047 |
| 10-K | 31 Dec 2018 | 8 Mar 2019 | 67 days | 0001698530-19-000015 |
| 10-Q | 30 Sep 2018 | 6 Nov 2018 | 37 days | 0001698530-18-000089 |
| 10-Q | 30 Jun 2018 | 6 Aug 2018 | 37 days | 0001698530-18-000044 |
| 10-Q | 31 Mar 2018 | 15 May 2018 | 45 days | 0001698530-18-000021 |
| 10-K | 31 Dec 2017 | 9 Mar 2018 | 68 days | 0001698530-18-000007 |
| 10-Q | 30 Sep 2017 | 14 Nov 2017 | 45 days | 0001628280-17-011566 |
| 10-Q | 31 Aug 2017 | 12 Sep 2017 | 12 days | 0001213900-17-009601 |
| 10-Q | 31 May 2017 | 11 Jul 2017 | 41 days | 0001213900-17-007439 |
Source: SEC EDGAR company submissions for CIK 0001698530. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.